Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
The Director, National Accounts role is an opportunity for an experienced payer account executive to help launch apitegromab, Scholar Rock’s investigational drug for the treatment of Spinal Muscular Atrophy (SMA). This team will have a direct impact on our ability to deliver value to patients and the trajectory of the company’s first launch. This role will be accountable for establishing Scholar Rock’s presence with key payers, achieving rapid, appropriate coverage for apitegromab in assigned accounts and regions, and supporting ongoing patient access efforts through launch.
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Relentlessly focused on seeing new possibilities in deep structural insights, validated biologies and antibody technologies to allow us to move with speed and urgency to deliver high-impact medicines to patients with devastating diseases.
4 jobsSubscribe to Rise newsletter